...
首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates
【24h】

Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates

机译:年龄和HLA等位基因对CMV - 血清阳性肾移植候选者CMV特异性细胞介导的免疫力

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor. We have read with interest the article by Cantisan and co-workers (1) reporting an association between certain human leukocyte antigen class I (HLA-I) alleles (HLA-A1 and HLA-A2) and the presence of pretransplant reactivity in the QuantiFERON-CMV (QF-CMV) assay in cytomegalovirus (CMV)-seropositive solid organ transplant (SOT) candidates. As they acknowledged, this finding might be confounded by the fact that the QF-CMV assay measures CMV-specific interferon-gamma (IFN-gamma)-producing CD8+ T cells mainly targeting viral epitopes on pp65 and immediate-early 1 (IE-1) proteins, whose presentation is restricted through the above-referred alleles (1,2). We sought to determine whether this association remains when CMV-specific IFN-7-producing CD8+ T cell response is assessed by flow cytometry for intracellular staining (ICS) using 15-mer overlapping peptide libraries spanning the entire sequence of pp65 and IE-1 viral proteins as the stimulating antigen. The ICS method is considered the reference procedure for measuring CMV-specific T cell responses, and 15-mer overlapping peptides are potentially presented in a broader HLA-I allele background (2,3). CMV-specific IFN-7-producing CD4+ and CD8+ T cells were enumerated by ICS in 43 CMV-seropositive patients listed for kidney transplantation (details available as Supporting Information). The HLA-A1 and HLA-A2 alleles were present in 10 (24.4%) and 17 (39.5%) patients. The magnitude of CMV-specific CD8+ T cell responses in patients harboring HLA-A1 and/or HLA-A2 alleles was comparable to that observed in patients with HLA-I alleles of other specificities (median 6.59 vs. 4.20 cells/(xL; p-value = 0.309). Interestingly, harboring the HLA-B44 allele (present in 11 [25.6%] patients) was associated with robust CMV-specific CD8+ T cell responses (median 9.88 vs. 4.06 cells/p,L; p-value = 0.016) (Figure 1 A). In fact, it was the only factor found to be associated with the magnitude of such response in a linear regression model (p = 0.366; p-value = 0.020). In turn, older age was not correlated with CMV-specific CD8+ T cell counts (Spearman's rho = -0.223; p-value = 0.155).
机译:到编辑。我们对坎施和同事(1)报告了某些人白细胞抗原类I(HLA-I)等位基因(HLA-A1和HLA-A2)之间的关联以及Quantiferon中的预体反应性的存在CytomeGalovirus(CMV) - 叠态固体器官移植(SOT)候选的-CMV(QF-CMV)测定。当他们承认时,这种发现可能会被QF-CMV测定测量CMV特异性干扰素-γ(IFN-Gamma)的事实诱惑,所述CD8 + T细胞主要针对PP65和立即提前1的病毒表位(IE-1 )蛋白质,其呈递通过上述等位基因(1,2)限制。我们试图确定这种关联是否保留在使用跨越PP65和IE-1病毒的整个序列的15-MER重叠的肽文库的细胞内染色(IC)的流式细胞术评估了CMV特异性IFN-7产生的CD8 + T细胞响应。蛋白质作为刺激抗原。 ICS方法被认为是测量CMV特异性T细胞应答的参考程序,并且可能在更广泛的HLA-1等位基因背景(2,3)中呈现15-ME重叠肽。 CMV特异性IFN-7产生的CD4 +和CD8 + T细胞被IC枚举,以肾移植列出的43个CMV-血清阳性患者(详情作为支持信息)。 HLA-A1和HLA-A2等位基因在10(24.4%)和17例(39.5%)患者中存在。 HLA-A1和/或HLA-A2等位基因患者的CMV特异性CD8 + T细胞应答的响应与其他特异性的HLA-I等位基因患者观察到的患者(中值6.59对4.20细胞/(XL; P. -Value = 0.309)。有趣的是,含HLA-B44等位基因(11例[25.6%]患者中存在)与鲁棒CMV特异性CD8 + T细胞反应有关(中值9.88对4.06细胞/ P,L; P值= 0.016)(图1A)。事实上,发现与线性回归模型中这种响应的大小相关的唯一因素(P = 0.366; p值= 0.020)。又是年龄与CMV特异性CD8 + T细胞计数没有相关(Spearman的Rho = -0.223; p值= 0.155)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号